About CEEK Enterprises
CEEK Enterprises is a company based in Boston (United States) founded in 2019 by Alex Hildebrandt was acquired by Two Labs in February 2020. CEEK Enterprises offers products and services including Commercial Launch, Compliance, Strategic Consulting, Medical Affairs, and REMS Solutions. CEEK Enterprises operates in a competitive market with competitors including Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.
- Headquarter Boston, United States
- Founders Alex Hildebrandt
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CEEK Enterprises
CEEK Enterprises offers a comprehensive portfolio of products and services, including Commercial Launch, Compliance, Strategic Consulting, Medical Affairs, and REMS Solutions.
Services for launching pharmaceutical products and market strategies.
Ensures adherence to industry standards and regulations.
Provides guidance on corporate and commercial strategies.
Supports clinical development and medical communications.
Offers programs for risk evaluation and mitigation strategies.
Funding Insights of CEEK Enterprises
Detailed funding history for CEEK Enterprises
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in CEEK Enterprises
CEEK Enterprises has secured backing from 1 investor. Prominent investors backing the company include Two Labs.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Market intelligence and commercialization services are provided by Two Labs.
|
Locked | Locked | Locked |
Investor details for CEEK Enterprises
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by CEEK Enterprises
Investment portfolio details for CEEK Enterprises
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - CEEK Enterprises
Detailed financials for CEEK Enterprises
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ceek Enterprises Comparisons
Peer comparison for CEEK Enterprises
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of CEEK Enterprises
CEEK Enterprises operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indegene, IntegriChain, Clinigen, Zuellig Pharma and Science Group, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Suite solutions are provided for payers and healthcare providers.
|
|
| Locked | Locked | Locked |
Inventory, order and customer relationship management solution for life science suppliers.
|
|
| Locked | Locked | Locked |
Specialty medicines are supplied via clinical trials and access programs.
|
|
| Locked | Locked | Locked |
Healthcare access in Asia is enhanced by Zuellig Pharma.
|
|
| Locked | Locked | Locked |
Technology-based consultancy and product development services are provided.
|
|
| Locked | Locked | Locked |
Strategic consulting services are provided to life sciences companies.
|
Detailed competitors of CEEK Enterprises
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ceek Enterprises
Complete news archive for CEEK Enterprises
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about CEEK Enterprises
CEEK Enterprises was founded in 2019.
CEEK Enterprises is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
CEEK Enterprises was founded in 2019 and is based in Boston, United States. Consulting services in the biopharma sector are provided, focusing on advisory support, market access strategies, commercialization efforts, and related operations. Expertise is directed toward assisting companies with sector-specific challenges, including regulatory navigation and business development. Operations remain centered in the U.S. pharmaceutical landscape.
CEEK Enterprises's top competitors include Indegene, Zuellig Pharma and IntegriChain.
CEEK Enterprises offers Commercial Launch, Compliance, Strategic Consulting, Medical Affairs, and REMS Solutions.
CEEK Enterprises has 1 investor. Key investors include Two Labs.